Skip Navigation



Bioinformatics Advance Access published online on August 9, 2005

Bioinformatics, doi:10.1093/bioinformatics/bti613
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
21/19/3701    most recent
bti613v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Xing, Y.
Right arrow Articles by Lee, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xing, Y.
Right arrow Articles by Lee, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2005). Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org
Received July 5, 2005
Revised August 3, 2005
Accepted August 3, 2005

Discovery note

Assessing the application of Ka/Ks ratio test to alternatively spliced exons

Yi Xing 1 and Christopher Lee 1*

1 Molecular Biology Institute, Center for Genomics and Proteomics, Dept. of Chemistry & Biochemistry, University of California, Los Angeles, Los Angeles, CA 90095-1570

* To whom correspondence should be addressed.
Christopher Lee, E-mail: leec{at}mbi.ucla.edu


   Abstract

Summary: Recently, the Ka/Ks ratio test, which assesses the protein-coding potentials of genomic regions based on their nonsynonymous to synonymous divergence rates, has been proposed and successfully used in genome annotations of eukaryotes. In this manuscript we systematically performed the Ka/Ks ratio test on 925 transcript-confirmed alternatively spliced exons in the human genome. We found that 22.3% of evolutionarily conserved alternatively spliced exons cannot pass the Ka/Ks ratio test, compared to 9.8% for constitutive exons. The false negative rate was the highest (85.7%) for exons with low frequencies of transcript inclusion. Analyses of alternatively spliced exons supported by full-length mRNA sequences yielded similar results, and nearly half of exons involved in ancestral alternative splicing events couldn't pass this test. Our analysis suggests a future direction to incorporate comparative genomics-based alternative splicing predictions with the Ka/Ks ratio test in higher eukaryotes with extensive RNA alternative splicing.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
Z. E. Sauna, C. Kimchi-Sarfaty, S. V. Ambudkar, and M. M. Gottesman
Silent Polymorphisms Speak: How They Affect Pharmacogenomics and the Treatment of Cancer
Cancer Res., October 15, 2007; 67(20): 9609 - 9612.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. H.-F. Zhang and L. A. Chasin
Comparison of multiple vertebrate genomes reveals the birth and evolution of human exons
PNAS, September 5, 2006; 103(36): 13427 - 13432.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
F.-C. Chen, S.-S. Wang, C.-J. Chen, W.-H. Li, and T.-J. Chuang
Alternatively and Constitutively Spliced Exons Are Subject to Different Evolutionary Forces
Mol. Biol. Evol., March 1, 2006; 23(3): 675 - 682.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.